monitoring rheumatological disease

FREE subscriptions for doctors and students... click here
You have 3 more open access pages.

Disease-modifying anti-rheumatic drugs (DMARDs) reduce tissue destruction by suppressing the auto-immune attack on the joints.

Serum acute phase proteins (ACP) are measured monthly to assess the effectiveness of DMARDs such as:

  • methotrexate
  • gold
  • sulphasalazine

Last reviewed 01/2018